Study on the dipeptide vinyl sulfonamide derivatives as proteasome inhibitor

doi:10.5246/jcps.2016.06.046

Journal of Chinese Pharmaceutical Sciences ›› 2016, Vol. 25 ›› Issue (6): 408-418.DOI: 10.5246/jcps.2016.06.046

• Original articles • Previous Articles Next Articles

Study on the dipeptide vinyl sulfonamide derivatives as proteasome inhibitor

Shuyang Yao, Yue Zhou^*

Shanghai Haini Pharmaceutical Co., Ltd. Yangtze River Pharmaceutical Group, Shanghai 201318, China

Received:2016-02-15 Revised:2016-03-25 Online:2016-06-29 Published:2016-04-15
Contact: Tel.: +86-021-68128999, E-mail: zhz296@163.com
Supported by:
Natural Science Foundation of China for the financial support (Grant No. 30772626).

Abstract

Abstract:

On the basis of the Michael-addition mechanism of classical proteasome inhibitors, six dipeptide vinyl sulfonamide and dipeptide vinyl sulfonate derivatives were designed and synthesized. Moreover, an efficient method for the synthesis of g-amino vinyl sulfonamides, key intermediates to the target molecules, was developed via the Wittig-Horner reaction of peptide aldehyde with Wittig reagents derived from methanesulfonamides.

Key words: Proteasome inhibitor, Dipeptide vinyl sulfonamides, Wittig-Horner reaction, g-Amino vinyl sulfonamide

CLC Number:

R916

Supporting:

Shuyang Yao, Yue Zhou. Study on the dipeptide vinyl sulfonamide derivatives as proteasome inhibitor[J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(6): 408-418.

References

[1] (a) Coux, O.; Tanaka, K.; Goldberg, A.L. Annu. Rev. Biochem. 1996, 65, 801-847. (b) Ciechanover, A. EMBO J. 1998, 17, 7151-7160. (c) Hendil, K.B.; Hartmann-Petersen, R. Curr. Protein Pept. Sci. 2004, 5, 135-151.
[2] Rock, K.; York, I.A.; Goldberg, A.L. Nat. Immunol. 2004, 5, 670-677.
[3] (a) Goldberg, A.L.; Rock, K. Nat. Med. 2002, 8, 338-340. (b) Myung, J.; Kim, K.B.; Crews, C.M. Med. Res. Rev. 2001, 21, 245-273.
[4] O’Connor, O.A.; Stewart, A.K.; Vallone, M.; Molineaux, C.J.; Kunkel, L.A.; Gerecitano, J.F.; Orlowski, R.Z. Clin. Cancer Res. 2009, 15, 7085-7091.
[5] Chauhan, D.; Catley, L.; Li, G.; Podar, K.; Hideshima, T.; Velankar, M.; Mitsiades, C.; Mitsiades, N.; Yasui, H.; Letai, A.; Ovaa, H.; Berkers, C.; Nicholson, B.; Chao, T.H.; Neuteboom, S.T.; Richardson, P.; Palladino, M.A.; Anderson, K.C. Cancer Cell. 2005, 8, 407-419.
[6] (a) Palmer, J.T.; Rasnick, D.; Klaus, J.L.; Bromme, D. J. Med. Chem. 1995, 38, 3193-3196. (b) Bromme, D.; Klaus, J.L.; Okamoto, K.; Rasnick, D.; Palmer, J.T. Biochem. J. 1996, 315, 85-89. (c) Rydzewski, R.M.; Burrill, L.; Mendonca, R.; Palmer, J.T.; Rice, M.; Tahilramani, R.; Bass, K.E.; Leung, L.; Gjerstad, E.; Janc, J.W.; Pan, L. J. Med. Chem. 2006, 49, 2953-2968. (d) Geurink, P.P.; Van der Linden, W.A.; Mirabella, A.C.; Gallastegui, N.; de Bruin, G.; Blom, A.E.M.; Voges, M.J.; Mock, E.D.; Florea, B.I.; van der Marel, G.A.; Driessen, C.; van der Stelt, M.; Groll, M.; Overkleeft, H.S.; Kisselev, A.F. J. Med. Chem. 2013, 56, 1262-1275.
[7] (a) Basse, N.; Piguel, S.; Papapostolou, D.; Ferrier-Berthelot, A.; Richy, N.; Pagano, M.; Sarthou, P.; Sobczak-Thépot, J.; Reboud-Ravaux, M.; Vidal, J. J. Med. Chem. 2007, 50, 2842-2850. (b) Baldisserotto, A.; Ferretti, V.; Destro, F.; Franceschini, C.; Marastoni, M.; Gavioli, R.; Tomatis, R. J. Med. Chem. 2010, 53, 6511-6515.
[8] Mauro, M.; Anna, B.; Silvia, C.; Riccardo, G.; Roberto, T. J. Med. Chem. 2005, 48, 5038-5042.
[9] (a) Basse, N.; Montes, M.; Maréchal, X.; Qin, L.; Bouvier-Durand, M.; Genin, E.; Vidal, J.; Villoutreix, B.O.; Reboud-Ravaux, M. J. Med. Chem. 2010, 53, 509-513. (b) Ge, Y.; Kazi, A.; Marsilio, F.; Luo, Y.; Jain, S.; Brooks, W.; Daniel, K.G.; Guida, W.C.; Sebti, S.M.; Lawrence, H.R. J. Med. Chem. 2012, 55, 1978-1998.
[10] Brouwer, A.J.; Jonker, A.; Werkhoven, P.; Kuo, E.; Li, N.; Gallastegui, N.; Kemmink, J.; Florea, B.I.; Groll, M.; Overkleeft, H.S.; Liskamp, R.M.J. J. Med. Chem. 2012, 55, 10995-11003.
[11] Jason, J.; Cheng, J.M.; William, R. Org. Lett. 2003, 5, 1967-1970.
[12] (a) Supuran, C.; Casini, A.; Scozzafava, A. Med. Res. Rev. 2003, 23, 535-558. (b) Roush, W.R.; Gwaltney, S.L.; Cheng, J.; Scheidt, K.A.; McKerrow, J.H.; Hansell, E. J. Am. Chem. Soc. 1998, 120, 10994-10995. (c) Palmer, J.T.; Rasnick, D.; Bromme, D. J. Med. Chem. 1995, 38, 3193-3196.
[13] Huang, J.X.; Widlanski, T. S. Tetrahedron Lett. 1992, 33, 2657-2660.
[14] Zhu, Y.Q.; Yao, S.Y.; Xu, B.; Ge, Z.M.; Cui, J.R.; Cheng, T.M.; Li, R.T. Bioorg. Med. Chem. 2009, 17, 6851-6861.

Study on the dipeptide vinyl sulfonamide derivatives as proteasome inhibitor

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 8

Recommended Articles

Metrics

Comments

[1]	Ting Sun, Xia Yuan, Wei Huang, Wei Guo, Zemei Ge, Runtao Li, Jingrong Cui . Effects and mechanism of proteasome inhibitor YSY01-A alone or in combination with cisplatin against A549 cells in vitro [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(9): 607-616.
[2]	Yixin Chen, Xia Yuan, Zemei Ge, Fuxiang Ran, Jun Wu, Runtao Li, Jingrong Cui . Effects of compound YSY-01A, a novel proteasome inhibitor, on MGC-803 cells and its related mechanism [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(9): 601-609.
[3]	Guanyu Yang, Qi Sun, Chao Wang, Lei Liang, Fengrong Xu, Yan Niu, Ping Xu. Design, synthesis and biological evaluation of sulfonamide flavone derivatives as potential 20S proteasome inhibitors [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(9): 626-630.
[4]	Zhe Wang, Xia Yuan, Zemei Ge, Fuxiang Ran, Jun Wu, Runtao Li, Jingrong Cui. A new proteasome inhibitor YSY-01A induced autophagy in PC-3M cells [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(8): 565-571.
[5]	Xuan Jia, Xia Yuan, Mingming Chu, Fuxiang Ran, Runtao Li^, Jingrong Cui^. Cell cycle arrest effect of compound YSY-01A, a new proteasome inhibitor, on SK-OV-3 cells [J]. Journal of Chinese Pharmaceutical Sciences, 2013, 22(6): 483-490.
[6]	Kan Tong, Jingtao Liu, Xia Yuan, Bo Xu, Wei Guo, Liqiang Han, Shuyang Yao, Zemei Ge, Runtao Li^, Jingrong Cui^. Cell cycle arrest effect of compound YSY-01A, a new proteasome inhibitor, on HT-29 cells in vitro [J]. , 2012, 21(5): 448-458.
[7]	Li-Qiang Han, Yu-An Zhang, Shu-Yang Yao, Bo Xu, Ze-Mei Ge, Jing-Rong Cui, Run-Tao Li^* . Study of the prodrugs of peptide aldehydes as proteasome inhibitors [J]. , 2012, 21(1): 21-27.
[8]	Gang Fu, Xiao-Min Zou, Yi-Qiu Fu, Ke Mou, Chao Ma, Yang Lu, Ping Xu^*. Synthesis of protected aminoalkyl sulfinyl dilactones from α-amino acids [J]. , 2007, 16(2): 119-124.